NZ762611A - Pharmaceutical compositions of therapeutically active compounds - Google Patents
Pharmaceutical compositions of therapeutically active compoundsInfo
- Publication number
- NZ762611A NZ762611A NZ762611A NZ76261115A NZ762611A NZ 762611 A NZ762611 A NZ 762611A NZ 762611 A NZ762611 A NZ 762611A NZ 76261115 A NZ76261115 A NZ 76261115A NZ 762611 A NZ762611 A NZ 762611A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- active compounds
- therapeutically active
- treating cancer
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- WIJZXSAJMHAVGX-DHLKQENFSA-N ivosidenib Chemical compound FC1=CN=CC(N([C@H](C(=O)NC2CC(F)(F)C2)C=2C(=CC=CC=2)Cl)C(=O)[C@H]2N(C(=O)CC2)C=2N=CC=C(C=2)C#N)=C1 WIJZXSAJMHAVGX-DHLKQENFSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided are compounds ( (S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide) and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461953480P | 2014-03-14 | 2014-03-14 | |
NZ723860A NZ723860A (en) | 2014-03-14 | 2015-03-13 | Pharmaceutical compositions of therapeutically active compounds and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ762611A true NZ762611A (en) | 2023-05-26 |
Family
ID=86613246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ762611A NZ762611A (en) | 2014-03-14 | 2015-03-13 | Pharmaceutical compositions of therapeutically active compounds |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ762611A (en) |
-
2015
- 2015-03-13 NZ NZ762611A patent/NZ762611A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501790A1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
PH12016501788A1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
PH12019501414A1 (en) | Amino acid compositions and methods for the treatment of liver diseases | |
PH12018500642A1 (en) | Anti-garp antibody | |
PH12018500097A1 (en) | Combination of pd-1 antagonist with an egfr inhibitor | |
JO3784B1 (en) | Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer | |
TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
MX2016016744A (en) | Ezh2 inhibitors for treating lymphoma. | |
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
MX2016002580A (en) | Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases. | |
IN2013MU03583A (en) | ||
MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
MX2022014792A (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same. | |
MX2022014763A (en) | Compositions of grapiprant and methods for using the same. | |
MX2018004532A (en) | Combination of trazodone and gabapentin for the treatment of pain. | |
NZ762611A (en) | Pharmaceutical compositions of therapeutically active compounds | |
NZ762612B2 (en) | Pharmaceutical compositions of therapeutically active compounds | |
MX2019001190A (en) | Sustained release composition comprising micronized tolcapone. | |
EA201892675A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ETHEPLIRSEN | |
IN2014DE00822A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: LES LABORATOIRES SERVIER SAS, FR Effective date: 20210602 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 MAR 2025 BY COMPUTER PACKAGES INC Effective date: 20240217 |